Among omics, the proteomics assumes a unique role in that it offers the effectors or actuators of a biological condition. This brief review attempts to summarize the development in a relatively new but important subdiscipline of proteomics, the so-called nascent proteomics, and its potential applications in stroke research. First, we will discuss a few examples of proteomics-led discoveries in stroke research, and challenges or unmet demands when using commonly practiced proteomics approaches. Then we will introduce nascent proteomics and its studying tools, followed by discussions on its potentials in stroke research.
WasingerVC, CordwellSJ, Cerpa-PoljakA, . Progress with gene-product mapping of the mollicutes: Mycoplasma genitalium. Electrophoresis1995;16:1090–4. doi:10.1002/elps.11501601185
2.
WilkinsMR, SanchezJC, GooleyAA, . Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev1995;13:19–50.
3.
AndersonNG, AndersonNL. Twenty years of two-dimensional electrophoresis: past, present and future. Electrophoresis1996;17:443–53. doi:10.1002/elps.1150170303
4.
KimMS, PintoSM, GetnetD, . A draft map of the human proteome. Nature2014;509:575–81. doi:10.1038/nature13302
5.
BentlageH, De CooR, Ter LaakH, . Human diseases with defects in oxidative phosphorylation. 1. Decreased amounts of assembled oxidative phosphorylation complexes in mitochondrial encephalomyopathies. Eur J Biochem1995;227:909–15.
LlombartV, García-BerrocosoT, Bech-SerraJJ, . Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC). J Proteomics2016;133:100–12. doi:10.1016/j.jprot.2015.12.011
8.
MaestriniI, DucroquetA, MoulinS, . Blood biomarkers in the early stage of cerebral ischemia. Rev Neurol (Paris)2016;172:198–219. doi:10.1016/j.neurol.2016.02.003
9.
PrenticeRL, PaczesnyS, AragakiA, . Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med2010;2:48. doi:10.1186/gm169
10.
LindL, SiegbahnA, LindahlB, . Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip. Stroke2015;46:3340–7. doi:10.1161/STROKEAHA.115.010829
11.
GrottaJC. Stroke Progress Review Group: summary of successes and lack of progress. Stroke2013;44(6 Suppl 1):S111–13. doi:10.1161/STROKEAHA.113.000970
12.
FyfeI. Stroke: proteomics chip yields three new markers that predict ischaemic stroke. Nat Rev Neurol2015;11:667.
13.
StapelsM, PiperC, YangT, . Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci Signal2010;3:ra15. doi:10.1126/scisignal.2000502
14.
ReynoldsJP, Miller-DelaneySF, Jimenez-MateosEM, . Transcriptional response of polycomb group genes to status epilepticus in mice is modified by prior exposure to epileptic preconditioning. Front Neurol2015;6:46. doi:10.3389/fneur.2015.00046
15.
Stenzel-PooreMP, StevensSL, XiongZ, . Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet2003;362:1028–37. doi:10.1016/S0140-6736(03)14412-1
16.
BaroneFC, WhiteRF, SperaPA, . Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke1998;29:1937–50; discussion 1950-1. doi:10.1161/01.STR.29.9.1937
17.
FrerichsKU, SmithCB, BrennerM, . Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc Natl Acad Sci USA1998;95:14511–16. doi:10.1073/pnas.95.24.14511
18.
SironiL, TremoliE, MillerI, . Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics. Stroke2001;32:753–60. doi:10.1161/01.STR.32.3.753
19.
DegraciaDJ, KumarR, OwenCR, . Molecular pathways of protein synthesis inhibition during brain reperfusion: implications for neuronal survival or death. J Cereb Blood Flow Metab2002;22:127–41. doi:10.1097/00004647-200202000-00001
20.
MengesdorfT, ProudCG, MiesG, . Mechanisms underlying suppression of protein synthesis induced by transient focal cerebral ischemia in mouse brain. Exp Neurol2002;177:538–46. doi:10.1006/exnr.2002.8002
21.
PaschenW, ProudCG, MiesG. Shut-down of translation, a global neuronal stress response: mechanisms and pathological relevance. Curr Pharm Des2007;13:1887–902. doi:10.2174/138161207780858401
22.
NowakTSJr. Protein synthesis and the heart shock/stress response after ischemia. Cerebrovasc Brain Metab Rev1990;2:345–66.
23.
BoisvertFM, AhmadY, GierlińskiM, . A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol Cell Proteomics2012;11:M111.011429. doi:10.1074/mcp.M111.011429
24.
PriceJC, GuanS, BurlingameA, . Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci USA2010;107:14508–13. doi:10.1073/pnas.1006551107
25.
KokuboY, LiuJ, RajdevS, . Differential cerebral protein synthesis and heat shock protein 70 expression in the core and penumbra of rat brain after transient focal ischemia. Neurosurgery2003;53:186–90; discussion 190-1. doi:10.1227/01.NEU.0000069023.01440.D6
26.
OngSE, MannM. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc2006;1:2650–60. doi:10.1038/nprot.2006.427
27.
UllrichM, LiangV, ChewYL, . Bio-orthogonal labeling as a tool to visualize and identify newly synthesized proteins in Caenorhabditis elegans. Nat Protoc2014;9:2237–55. doi:10.1038/nprot.2014.150
28.
DieterichDC, LinkAJ, GraumannJ, . Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc Natl Acad Sci USA2006;103:9482–7. doi:10.1073/pnas.0601637103
29.
DieterichDC, LeeJJ, LinkAJ, . Labeling, detection and identification of newly synthesized proteomes with bioorthogonal non-canonical amino-acid tagging. Nat Protoc2007;2:532–40. doi:10.1038/nprot.2007.52
30.
Reckow SWebhoferC. Analysis of individual protein turnover in live animals on a proteome-wide scale. Methods Mol Biol2014;1156:147–54. doi:10.1007/978-1-4939-0685-7_9
31.
ShenW, LiuHH, SchiapparelliL, . Acute synthesis of CPEB is required for plasticity of visual avoidance behavior in Xenopus. Cell Rep2014;6:737–47. doi:10.1016/j.celrep.2014.01.024
32.
HolmesWE, AngelTE, LiKW, . Dynamic proteomics: in vivo proteome-wide measurement of protein kinetics using metabolic labeling. Meth Enzymol2015;561:219–76. doi:10.1016/bs.mie.2015.05.018
33.
DieterichDC, KreutzMR. Proteomics of the synapse—a quantitative approach to neuronal plasticity. Mol Cell Proteomics2016;15:368–81. doi:10.1074/mcp.R115.051482
34.
SavasJN, ParkSK, YatesJRIII. Proteomic analysis of protein turnover by metabolic whole rodent pulse-chase isotopic labeling and shotgun mass spectrometry analysis. Methods Mol Biol2016;1410:293–304. doi:10.1007/978-1-4939-3524-6_18
35.
ZhouA, SimonRP, DavidL. Nascent proteomes of ischemic-injured and ischemic-tolerant neuronal cells. Int J Comput Biol Drug Des2011;4:40–55. doi:10.1504/IJCBDD.2011.038656
36.
JicklingGC, StamovaB, AnderBP, . Profiles of lacunar and nonlacunar stroke. Ann Neurol2011;70:477–85. doi:10.1002/ana.22497
37.
SharpFR, JicklingGC, StamovaB, . Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab2011;31:1513–31. doi:10.1038/jcbfm.2011.45
38.
MellerR, PearsonAN, HardyJJ, . Blood transcriptome changes after stroke in an African American population. Ann Clin Transl Neurol2016;3:70–81. doi:10.1002/acn3.272
39.
BianF, SimonRP, LiY, . Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke. Stroke2014;45:1177–9. doi:10.1161/STROKEAHA.113.004576
